About
Julian C. Baker has served as an ACADIA director since December 2015. He is a Managing Member of Baker Bros. Advisors LP, a registered investment adviser focused on long-term investments in life-sciences companies, which he co-founded in 2000 with his brother, Felix Baker, Ph.D. He previously was a portfolio manager at Tisch Financial Management and worked in the private-equity arm of Credit Suisse First Boston. He currently serves on the boards of Incyte Corporation, Madrigal Pharmaceuticals and Denali Therapeutics.
Roles
Acadia Pharmaceuticals Inc.
Director · Current role
December 2015–present
Baker Bros. Advisors LP
Managing Member
2000 - present
Tisch Financial Management
Portfolio Manager
1994 - 1999
Credit Suisse First Boston
Private equity investment arm
1988 - 1993
External Roles
Incyte Corporation
Director
—
Madrigal Pharmaceuticals, Inc.
Director
—
Denali Therapeutics, Inc.
Director
—
Director Compensation
FY 2025Fees earned or paid in cash
$27,952
ComponentAnnual Board and committee cash retainers earned in FY2025
Option awards
$176,392
ComponentAnnual stock option grant, ASC 718 grant-date fair value
Stock awards
$180,705
ComponentAnnual restricted stock unit grant, ASC 718 grant-date fair value
Total
$385,049
Also at Acadia Pharmaceuticals Inc.
See how Top Bucket AI works for your firm
Request DemoTop Bucket AI Research
Stay ahead of private markets
Research and market intelligence for private-markets professionals.
✓
You're subscribed.
Thanks for signing up.